Equipment Qualified. Inspection-Ready.
From DQ through PQ and thermal mapping - equipment and utility qualification built to satisfy EU GMP, WHO, and FDA requirements.
PHARPRO CQV consulting delivers complete Commissioning, Qualification, and Validation services - from DQ through IQ/OQ/PQ and thermal mapping - for pharmaceutical equipment and utilities in Jordan, UAE, Saudi Arabia, and across the MENA region. All documentation is formatted for EU GMP Annex 15, WHO, and FDA inspection dossiers. Fixed-price engagements, no hourly billing.
Start your CQV project
Tell us about your equipment or facility - we'll respond within one business day with a clear scope and fixed-price proposal.
What's included in a CQV package?
Every engagement produces a full documentation trail - from qualification planning through final summary report - that holds up in any GMP or WHO inspection.
Qualification Plan (QP)
Site or project-level Qualification Plan defining scope, responsibilities, acceptance criteria, and the qualification strategy for all equipment and utilities in scope.
Design Qualification (DQ)
Documented review confirming that equipment and system designs meet GMP user requirements and regulatory expectations before procurement or build.
IQ / OQ / PQ Protocols & Execution
Installation, Operational, and Performance Qualification protocols written to your equipment specifics - executed on-site, with full discrepancy management and CAPA documentation.
Thermal Mapping Studies
Temperature distribution studies for cold rooms, freezers, refrigerators, incubators, ovens, and autoclaves - with calibrated data loggers, sensor placement maps, and full statistical analysis.
Utilities Qualification
Qualification of HVAC systems, purified water (PW), water for injection (WFI), compressed air, and clean steam - aligned with EU GMP Annex 1 and relevant pharmacopoeial standards.
Qualification Summary Report (QSR)
Final closure report consolidating all qualification activities, test results, discrepancies, and residual risks - formatted for regulatory submissions and inspection readiness.
Which standards does PHARPRO's CQV work align to?
All CQV and thermal mapping work is written to the current version of each guideline, with explicit cross-references so inspectors can trace every requirement.
| Framework | Scope | Applies To |
|---|---|---|
| EU GMP Annex 15 | Qualification and validation of equipment, utilities, and processes | EMA / EU-regulated manufacturers |
| WHO TRS 937 / 961 | Qualification of equipment and temperature-controlled storage | WHO-regulated and prequalification markets |
| ISPE Baseline Guide Vol. 5 | Commissioning and qualification risk-based approach | All regulated pharma environments |
| ICH Q10 | Pharmaceutical Quality System and lifecycle management | Global regulated markets |
Common CQV questions
Review relevant delivery history
PHARPRO publishes factual project scopes and evidence status instead of anonymous star ratings. Client logos, quotations and measurable outcomes remain withheld until reuse permission is confirmed.
View project record →Go deeper on CQV and qualification
In-depth guides from Mohammad Awawdeh on IQ/OQ/PQ, thermal mapping, EU GMP Annex 15, and equipment qualification best practice.
Complete compliance support
Related Reading
Why PHARPRO
Practical CQV and thermal mapping support with audit-defensible outputs
PHARPRO aligns each engagement with the regulations and guidance applicable to the client’s product, market and quality system. Final responsibility and approval remain with the regulated company.
More questions
How long does a pharmaceutical warehouse thermal mapping study take from start to final report?
A pharmaceutical warehouse thermal mapping study typically takes 6–10 weeks from kick-off to final report. This includes sensor placement planning (1 week), calibration certificate collection (1 week), data collection period — usually 7 continuous days minimum for each season per WHO Technical Report 1010 (1–2 weeks), data analysis and report writing (2–3 weeks), and review and approval (1–2 weeks). PHARPRO provides both summer and winter studies where required, with each producing a standalone report and a combined mapping programme conclusion.
Which pharmaceutical facilities in Jordan, UAE, and Saudi Arabia require thermal mapping?
Any pharmaceutical storage or manufacturing facility holding temperature-sensitive products requires thermal mapping under WHO GDP, EU GMP, and national authority (JFDA, SFDA, UAE MOH) requirements. This includes: ambient warehouses (15–25°C or 15–30°C), refrigerated cold rooms (2–8°C), freezer stores (-20°C), walk-in stability chambers, and distribution vehicles for cold chain products. PHARPRO delivers thermal mapping studies for pharmaceutical facilities across Jordan, UAE, Saudi Arabia, Egypt, and the wider MENA region — producing WHO-aligned reports ready for regulatory submission.